ApoE genotype and cardiovascular risk biomarkers: impact of gender and BMI (the FINGEN Study)

The FINGEN intervention trial (n 312; mean age 45 (sd 1) years and BMI 25.2 (sd 0.2) kg/m2) examined the impact of age, gender and apoE genotype (with prospective recruitment on the basis of these variables) on the response of over forty established and putative CHD risk indicators to modest-dose fi...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the Nutrition Society 2010, Vol.69 (OCE1), Article E20
Main Authors: Miles, E. A., Kofler, B. M., Curtis, P., Armah, C. K., Lietz, G., Caslake, M. J., Packard, C. J., Mathers, J. C., Williams, C. M., Calder, P. C., Minihane, A. M.
Format: Article
Language:English
Subjects:
Cardiovascular disease
Cell adhesion & migration
Fish oils
Health risks
Human subjects
Proteins
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The FINGEN intervention trial (n 312; mean age 45 (sd 1) years and BMI 25.2 (sd 0.2) kg/m2) examined the impact of age, gender and apoE genotype (with prospective recruitment on the basis of these variables) on the response of over forty established and putative CHD risk indicators to modest-dose fish oil intake.
ISSN:0029-6651
1475-2719
DOI:10.1017/S0029665109992084